Warning letter

PCI Synthesis [ARCHIVED]: warning letter of Dec 2, 2010

FDA warning letter UCM256984 · New England District Office

Key facts

Reference number UCM256984
Company PCI Synthesis [ARCHIVED]
Subject CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated
Issue date Dec 2, 2010
Posted date Dec 2, 2010
Issuing office New England District Office
Product type Unknown
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters